Haihong Mao, MD
Family Medicine · Indianapolis, INNPI 1023225901
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,100 of the $14,103 with a category attached, or 71.6%. SPR Therapeutics, Inc accounts for 80.7% of it on its own, with 8 other manufacturers making up the rest. Among family medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $227.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$11K
- Si-bone, Inc.$1K
- Pacira Pharmaceuticals Incorporated$673
- Curonix LLC$305
- Samsung HME America, Inc.$250
- Astellas Pharma US Inc$125
- plus $236 from 3 others
Across 1 payment — averaging $9220.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- SPR Therapeutics, Inc$9K
What the payments were for
- Consulting fees$10,10072%
- Travel & lodging$1,72312%
- Food & beverage$2,28016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 39 | $11,383 |
| Si-bone, Inc. | 8 | $1,130 |
| Pacira Pharmaceuticals Incorporated | 4 | $673 |
| Curonix LLC | 2 | $305 |
| Samsung HME America, Inc. | 2 | $250 |
| Astellas Pharma US Inc | 1 | $125 |
| Avanos Medical | 1 | $85 |
| Exact Sciences | 4 | $79 |
| Abbott | 1 | $71 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,103 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 77 | $1,645 |
| Diclofenac Sodium | 27 | $654 |
| Gabapentin | 70 | $409 |
| Cyclobenzaprine Hcl | 24 | $240 |
| Tizanidine Hcl | 13 | $225 |
| Ibuprofen | 15 | $144 |
| Meloxicam | 25 | $61 |
| Prednisone | 20 | $54 |
| Tramadol Hcl | 14 | $50 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Indianapolis
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Joe BanksIndianapolis$294K
- Jakoda SniderIndianapolis$107K
- Robert ClutterIndianapolis$77K
- Blair BrengleIndianapolis$17K
- James AndryBloomington$715K
- Anthony InzerelloEvansville$308K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.